12-hour Time Limited Feeding in Critical Care

April 27, 2026 updated by: Felicia Steger, University of Kansas Medical Center

The Safety and Feasibility of a 12-hour Time-Limited Enteral Feeding Protocol in Critically Ill Adults

This study is being done to assess the feasibility and safety of a time-restricted 12-hour enteral feeding protocol (experimental group) in comparison to a standard-of-care, 24-hour enteral feeding protocol (control group) in critically ill patients. Investigators hope to gain knowledge about how these feeding schedules affect feeding tolerance, blood sugar control, and other factors affecting critically ill adult patients.

  • Investigators expect that the 12-hour feeding protocol will be tolerated similarly to the 24-hour feeding protocol and will not result in a greater number of adverse events related to feeding.
  • Investigators expect that the proportion of participants in both groups receiving at least 75% of their estimated nutrition needs will be similar.

Study Overview

Detailed Description

Investigators will test a 12-hour time-restricted feeding (TRF12) protocol in critically ill adults and compare this to a standard-of-care, 24-hour continuous feeding (CONT24) schedule. Time-restricted feeding (TRF) is form of intermittent fasting involving eating within a consistent, shortened period each day, following by fasting for at least 12 hours daily. TRF may improve glycemic control, blood pressure, and circadian rhythms in metabolism relative to feeding over a longer period. In critically ill patients, most facilities feed enterally over 24-hours which may exacerbate sleep disturbances and post-intensive care syndrome. In addition to safety and feasibility measures, this 10-day trial will gather preliminary data regarding how these feeding protocols each affect glycemic control, sleep, and long-term effects of critical care, such as delirium.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kansas
      • Kansas City, Kansas, United States, 66103
        • University of Kansas Health System

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults (≥18 years of age)
  • With critical illness (hospitalized in an intensive care unit with a status of "ICU")
  • Who have received orders for continuous enteral nutrition

Exclusion Criteria:

  • "Comfort Measures Only" status
  • Have orders to receive trickle feedings (feeding rate ≤10mL/hr)
  • Recent surgical procedure on the GI tract (within previous 5 days at time of recruitment) or admission for GI bleed
  • Receiving continuous sedation
  • Expected to undergo a procedure requiring removal of study devices in the three days following enrollment
  • History of malabsorptive bariatric surgery
  • Admitted for a burn injury
  • Known intolerance to feeding rates >100mL/hr
  • Current diagnosis of pancreatitis, ileus or gastroparesis (only if using a gastrostomy tube)
  • Requiring intermittent or continuous renal replacement therapy
  • Pregnant or lactating
  • On an intermittent feeding schedule
  • Nutritional needs would require a rate higher than 120mL/hr on TRF12 protocol
  • Lack of clearance by primary physician

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Continuous 24 hour feeding (CONT24).
24 hour tube feeding is the standard of care. They will receive tube feeding continuously over 24 hours daily.
Patients in this control group will receive the standard of care which is tube feeding continuously over 24 hours.
Experimental: 12-hour time-restricted feeding (TRF12)
The 12-hour time-restricted feeding group will receive the same amount of nutrition in 12 hours as would be needed in 24 hours. The hourly feeding rate will double.
The 12 hour feeding group will receive tube feeding only over a 12 hour period (6:00 AM to 6:00 PM feeding schedule).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Safety and feasibility
Time Frame: From randomization up to 10 days
Safety will be measured by the need for pausing or discontinuing enteral feeds, gastrointestinal complications (including vomiting, abdominal distention, and diarrhea), other feeding complications (e.g., aspiration, gastric residuals), and hypoglycemic events. Feasibility is defined as the percentage of patients who received ≥75% of their prescribed nutrition goal, and the logistical feasibility of collecting study data.
From randomization up to 10 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glycemic control
Time Frame: From randomization up to 10 days
Glycemic control will be assessed using a continuous glucose monitor to measure time-in-range (%), time-above-range, and number of hypoglycemic events.
From randomization up to 10 days
Sleep quantity
Time Frame: From randomization up to 10 days
Sleep quantity scores will be measured in hours using actigraphy and the Richards-Campbell Sleep questionnaire.
From randomization up to 10 days
Circadian rhythm of skin surface temperature
Time Frame: From randomization up to 10 days
Circadian rhythm of skin surface temperature will be measured across 24-hours and the phase and amplitude of the circadian rhythm of skin temperature will be quantified
From randomization up to 10 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive health
Time Frame: From 1 month and 3 months post-discharge
National Institutes of Health Patient Reported Outcomes Measurement Information System-29 (PROMIS-29) will be used to assess depression or anxiety as a T-score two standard deviations above the mean. A higher score in each category indicates more of the concept being measured.
From 1 month and 3 months post-discharge
Mental health
Time Frame: From 1 month and 3 months post-discharge
Mental health will be measured using the Personal Health Questionnaire-9 (PHQ-9). To provide a numerical score, we will assess anxiety, depression, and post-traumatic stress syndrome. The total score ranges from 0 to 27, with higher scores indicating more severe anxiety, depression and post-traumatic stress syndrome.
From 1 month and 3 months post-discharge
Impact of Health Status on Quality of life
Time Frame: From 1 month and 3 months post-discharge
Investigators will use the Health-Related Quality of Life survey to provide a measure of the impact of health status on quality of life.
From 1 month and 3 months post-discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Felicia Steger, PhD, MS, RD, University of Kansas Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 25, 2025

Primary Completion (Actual)

March 4, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

December 4, 2024

First Submitted That Met QC Criteria

December 17, 2024

First Posted (Actual)

December 19, 2024

Study Record Updates

Last Update Posted (Actual)

April 28, 2026

Last Update Submitted That Met QC Criteria

April 27, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on Continuous 24 hour feeding (CONT24).

Subscribe